The Health Revival Show podcast

#894: Ozempic 2.0? Fat Loss, Insulin, and the Future

0:00
34:55
Reculer de 15 secondes
Avancer de 15 secondes
In this episode of The Health Revival Show, Liz & Becca break down Retatrutide—a new GLP-1, GIP, and glucagon receptor agonist that’s making waves in the functional health and metabolic space. Is it really “Ozempic on steroids”? They cut through the hype and bring the context no one’s talking about—the importance of muscle preservation, insulin sensitivity, thyroid health, and how to use these tools responsibly (or if at all). Whether you’re considering peptides or just curious about this next-gen weight loss compound, this episode delivers the no-BS truth.

D'autres épisodes de "The Health Revival Show"